// App-Quantinova.ai

P668 : Post-marketing experience of vedolizumab in inflammatory bowel disease: analysis of pneumonia and other respiratory tract infections

Researchers

Presenter

  • F. Bhayat

Principal Investigators

  • A. Blake

  • S. Travis

Medical Centers

  • Takeda Development Center Europe Ltd, Global Pharmacovigilance, London, United Kingdom

  • Takeda Development Center Europe Ltd, Global Pharmacovigilance, London, United Kingdom

  • University of Oxford, Translational Gastro-Intestinal Unit- Nuffield Department of Medicine, Oxford, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Gastroenterology (GU)

  • Infectious Diseases (ID)

  • Genetic Disorder

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • Entyvio

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved